Apoptosis of multiple CML cell lines including blast-phase CML CD34+ cells was achieved by increasing ceramide level with the addition of the short chain ceramide analog C2-ceramide or pharmacological inhibition of ceramide metabolizing enzymes with PDMP and SKI-II [197]. This evidence concerns the gene CD34 and chronic myelogenous leukemia, BCR-ABL1 positive.